AbbVie
ABBV
#25
Rank
โ‚น48.683 T
Marketcap
โ‚น27,542
Share price
0.68%
Change (1 day)
42.04%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น806.12 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น64.38 Billion. In 2025 the company made an earning of โ‚น619.47 Billion, an increase over its 2024 earnings that were of โ‚น348.94 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น806.12 B30.13%
2025 โ‚น619.47 B77.53%
2024 โ‚น348.94 B-40.54%
2023 โ‚น586.89 B-53.62%
2022 โ‚น1.265 T3.76%
2021 โ‚น1.219 T282.25%
2020 โ‚น319.08 B-59.67%
2019 โ‚น791.22 B62.13%
2018 โ‚น488.01 B-32.74%
2017 โ‚น725.58 B-1.99%
2016 โ‚น740.33 B18.65%
2015 โ‚น623.98 B180.5%
2014 โ‚น222.45 B-55.57%
2013 โ‚น500.69 B-6.86%
2012 โ‚น537.58 B56.05%
2011 โ‚น344.48 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น648.58 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.264 T 299.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น965.98 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น94.97 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น183.59 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.064 T 30.27%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.345 T 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น671.82 B-17.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น76.84 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA